ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin

Journal of Immunology

Volumn 181, Issue 4, 2008, Pages 2533-2543

  Obeid, Michel ^a  

^a GenCal   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; MEMBRANE PROTEIN; MEMBRANE PROTEIN ERP57; MOLECULAR MARKER; RECOMBINANT CALRETICULIN; RECOMBINANT ERP57; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; MITOXANTRONE; PDIA3 PROTEIN, MOUSE; PROTEIN DISULFIDE ISOMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL DEATH; CONTROLLED STUDY; DENDRITIC CELL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; EXPOSURE; FEMALE; GENE TRANSLOCATION; GENETIC TRANSFECTION; IMMUNOGENICITY; IN VIVO STUDY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TUMOR CELL; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL LINE; CELL MEMBRANE; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; CALRETICULIN; CELL DEATH; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; ENDOPLASMIC RETICULUM; FEMALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOXANTRONE; NEOPLASM TRANSPLANTATION; PHAGOCYTOSIS; PROTEIN DISULFIDE-ISOMERASE; PROTEIN TRANSPORT; RNA, SMALL INTERFERING;

EID: 53149137847     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.4.2533     Document Type: Article

References (26)

1. Obeid, M., A. Tesniere, T. Panaretakis, R. Tufi, N. Joza, P. van Endert, F. Ghiringhelli, L. Apetoh, N. Chaput, C. Flament, et al. 2007. Ecto-calreticulin in immunogenic chemotherapy. Immunol. Rev. 220: 22-34.
2. Obeid, M., A. Tesniere, F. Ghiringhelli, G. M. Fimia, L. Apetoh, J. L. Perfettini, M. Castedo, G. Mignot, T. Panaretakis, N. Casares, et al. 2007. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13: 54-61.
3. Obeid, M., T. Panaretakis, N. Joza, R. Tufi, A. Tesniere, P. van Endert, L. Zitvogel, and G. Kroemer. 2007. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ. 14: 1848-1850.
4. Johnson, S., M. Michalak, M. Opas, and P. Eggleton. 2001. The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol. 11: 122-129.
5. Michalak, M., E. F. Corbett, N. Mesaeli, K. Nakamura, and M. Opas. 1999. Calreticulin: one protein, one gene, many functions. Biochem. J. 344: 281-292.
6. Trombetta, E. S., and A. J. Parodi. 2003. Quality control and protein folding in the secretory pathway. Annu. Rev. Cell Dev. Biol. 19: 649-676.
7. Trombetta, E. S. 2003. The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis. Glycobiology 13: 77R-91R.
8. + signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 32: 269-278.
9. Frickel, E. M., R. Riek, I. Jelesarov, A. Helenius, K. Wuthrich, and L. Ellgaard. 2002. TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain. Proc. Natl. Acad. Sci. USA 99: 1954-1959.
10. Booth, C., and G. L. Koch. 1989. Perturbation of cellular calcium induces secretion of luminal ER proteins. Cell 59: 729-737.
11. Patton, W. F., H. Erdjument-Bromage, A. R. Marks, P. Tempst, and M. B. Taubman. 1995. Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. Identification by comparative protein phenotyping and microsequencing. J. Biol. Chem. 270: 21404-21410.
12. Sueyoshi, T., B. A. McMullen, L. L. Marnell, T. W. Du Clos, and W. Kisiel. 1991. A new procedure for the separation of protein Z, prothrombin fragment 1.2 and calreticulin from human plasma. Thromb. Res. 63: 569-575.
13. Zhu, Q., P. Zelinka, T. White, and M. L. Tanzer. 1997. Calreticulin-integrin bidirectional signaling complex. Biochem. Biophys. Res. Commun. 232: 354-358.
14. Kwon, M. S., C. S. Park, K. Choi, J. Ahnn, J. I. Kim, S. H. Eom, S. J. Kaufman, and W. K. Song. 2000. Calreticulin couples calcium release and calcium influx in integrin-mediated calcium signaling. Mol. Biol. Cell 11: 1433-1443.
15. Gray, A. J., P. W. Park, T. J. Broekelmann, G. J. Laurent, J. T. Reeves, K. R. Stenmark, and R. P. Mecham. 1995. The mitogenic effects of the Bβ chain of fibrinogen are mediated through cell surface calreticulin. J Biol. Chem. 270: 26602-26606.
16. White, T. K., Q. Zhu, and M. L. Tanzer. 1995. Cell surface calreticulin is a putative mannoside lectin which triggers mouse melanoma cell spreading. J. Biol. Chem. 270: 15926-15929.
17. Obeid, M., T. Panaretakis, A. Tesniere, N. Joza, R. Tufi, L. Apetoh, F. Ghiringhelli, L. Zitvogel, and G. Kroemer. 2007. Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic. Cancer Res. 67: 7941-7944.
18. Nakamura, K., A. Zuppini, S. Arnaudeau, J. Lynch, I. Ahsan, R. Krause, S. Papp, H. De Smedt, J. B. Parys, W. Muller-Esterl, et al. 2001. Functional specialization of calreticulin domains. J. Cell Biol. 154: 961-972.
19. Culina, S., G. Lauvau, B. Gubler, and P. M. van Endert. 2004. Calreticulin promotes folding of functional human leukocyte antigen class I molecules in vitro. J. Biol. Chem. 279: 54210-54215.
20. Hetz, C., M. Russelakis-Carneiro, S. Walchli, S. Carboni, E. Vial-Knecht, K. Maundrell, J. Castilla, and C. Soto. 2005. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J. Neurosci. 25: 2793-2802.
21. Gottardi, C. J., L. A. Dunbar, and M. J. Caplan. 1995. Biotinylation and assessment of membrane polarity: caveats and methodological concerns. Am. J. Physiol. 268: F285-F295.
22. + channel expressed in epithelial Madin-Darby canine kidney cells. J. Biol. Chem. 277: 9772-9779.
23. Gardai, S. J., K. A. McPhillips, S. C. Frasch, W. J. Janssen, A. Starefeldt, J. E. Murphy-Ullrich, D. L. Bratton, P. A. Oldenborg, M. Michalak, and P. M. Henson. 2005. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123: 321-334.
24. Storkus, W. J., and L. D. Falo, Jr. 2007. A 'good death' for tumor immunology. Nat. Med. 13: 28-30.
25. Clarke, C., and M. J. Smyth. 2007. Calreticulin exposure increases cancer immunogenicity. Nat. Biotechnol. 25: 192-193.
26. Ellgaard, L., and A. Helenius. 2001. ER quality control: towards an understanding at the molecular level. Curr. Opin. Cell Biol. 13: 431-437.